サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1564072

細胞計数の世界市場

Cell Counting

出版日
ページ情報
英文 182 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
細胞計数の世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

細胞計数の世界市場は2030年までに220億米ドルに達する見込み

2023年に153億米ドルと推定される細胞計数の世界市場は、分析期間2023-2030年にCAGR 5.3%で成長し、2030年には220億米ドルに達すると予測されます。細胞計数消耗品は、本レポートで分析したセグメントの1つであり、CAGRは6.0％を記録し、分析期間終了時には129億米ドルに達すると予測されます。細胞計数機器セグメントの成長率は、分析期間でCAGR 4.5％と推定されます。

米国市場は42億米ドル、中国はCAGR 5.0％で成長予測

米国の細胞計数市場は、2023年に42億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに34億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは5.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.2%と4.1%と予測されています。欧州では、ドイツがCAGR 4.3%で成長すると予測されています。

世界の細胞計数市場- 主要動向と促進要因のまとめ

細胞計数はバイオテクノロジーと医学の研究をどのように進めているのか？

細胞計数は、バイオテクノロジー、ライフサイエンス、医学研究における基本的な技術となっており、細胞の挙動、成長、治療に対する反応に関する重要な洞察を提供しています。このプロセスには、与えられたサンプル中の細胞を定量化することが含まれ、薬剤スクリーニングにおける細胞生存率の評価から細胞培養における濃度の決定まで、幅広いアプリケーションに不可欠です。細胞計数は、細胞増殖率を理解することが新しい治療法の開発に直接影響するがん研究などの分野で不可欠です。また、バイオ医薬品の製造においても、安定した製品収量と品質管理のために正確な細胞数が必要であり、非常に重要です。さらに、細胞計数は免疫学、微生物学、血液学において、病気の進行や治療介入の有効性をモニターするために広く使用されています。研究、診断、治療開発のいずれにおいても、最新の細胞計数の精度と効率性は、科学的知識と医療技術革新の進歩に極めて重要な役割を果たしています。

細胞計数自動化技術の需要が高まっている理由とは？

自動化された細胞計数テクノロジーへの需要が高まっているのは、研究と臨床の両方の場面で、正確性、効率性、拡張性が求められているからです。手作業による細胞計数は、顕微鏡下で血球計数装置を使って行われることが多く、手間がかかり、人為的ミスが起こりやすく、ハイスループットのアプリケーションには不向きです。対照的に、自動化された細胞計数システムは、迅速、正確、再現性のある結果を提供し、研究者や臨床医が大量のサンプルを大幅に短時間で処理することを可能にします。これらのシステムは、数百から数千のサンプルにわたる細胞の生存率と増殖を迅速に分析する能力が創薬と開発に不可欠である、製薬研究において特に価値があります。さらに、特に腫瘍学、幹細胞研究、再生医療などの分野では、生物学的研究の複雑さが増しており、細胞ベースの実験量の増加に対応するため、より洗練されたツールが必要とされています。高度なイメージングとフローサイトメトリー機能を備えた自動セルカウンターは、高解像度データを提供し、異種細胞集団を含むような複雑なアッセイをサポートすることで、これらのニーズに応えています。ユーザーフレンドリーなソフトウェア・インターフェースとデータ解析ツールの統合は、これらのシステムの魅力をさらに高め、世界中の検査室や病院での採用を後押ししています。

技術の進歩はどのように細胞計数技術を変革しているか？

技術の進歩は細胞計数を変革し、研究者や臨床医が利用できるツールの精度と機能の両方を向上させています。フローサイトメトリー、画像ベースの細胞計数、マイクロ流体デバイスなどの革新は、より精密でハイスループットな細胞分析を可能にしています。特にフローサイトメトリーでは、何千もの細胞を同時にカウントし、その物理的・化学的特性に基づいて特徴づけを行うことができるため、免疫フェノタイピングやがん研究などのアプリケーションに最適です。画像ベースの細胞計数は、高度な顕微鏡とソフトウエア・アルゴリズムを使って細胞画像を解析するもので、細胞の形態や生存率に関する詳細なデータを提供できることから、ますます人気が高まっています。さらに、色素や染色を必要とせず、細胞増殖をリアルタイムでモニタリングできるラベルフリー技術の出現により、研究対象の細胞に対する外部薬剤の影響が軽減され、細胞の自然な挙動が保たれています。人工知能（AI）や機械学習を取り入れた自動化システムは、細胞計数技術の能力をさらに高め、大規模なデータセットに基づく細胞挙動のより正確な予測や分析を提供しています。これらの技術革新により、細胞計数はより速く、より信頼性が高く、より汎用的になり、研究や臨床診断への応用が拡大しています。

細胞計数市場の主な成長促進要因は？

細胞計数市場の成長は、慢性疾患の増加、バイオテクノロジーの進歩、個別化医療への需要の高まりなど、いくつかの要因によってもたらされます。主な促進要因の1つは、疾病調査や診断における正確な細胞分析のニーズの高まりです。がん、糖尿病、感染症の世界の罹患率が増加の一途をたどる中、細胞計数テクノロジーは疾患の進行をモニタリングし、治療の有効性を評価するために不可欠です。さらに、バイオ医薬品産業、特に生物製剤やワクチンの製造の拡大により、一貫した製品品質を確保するための精密な細胞計数の需要が高まっています。自動化されたハイスループット細胞計数システムの開発などの技術的進歩は、研究ワークフローのスピードと精度を向上させ、市場の成長をさらに促進しています。個々の患者に合わせた治療を行うために精密な細胞分析を必要とする個別化医療への傾向の高まりも、高度な細胞計数技術への需要を押し上げています。さらに、再生医療における幹細胞の使用の増加や、医薬品開発における細胞ベースのアッセイの拡大は、細胞計数ソリューションの新たな機会を生み出しています。最後に、臨床診断、特に血液学と免疫学における細胞計数技術の採用は、ヘルスケアプロバイダーが患者ケアのためのより正確なツールを求めているため、市場拡大の原動力となっています。これらの要因が、ライフサイエンス研究への投資の増加と相まって、細胞計数市場の堅調な成長を今後数年間維持すると予想されます。

調査対象企業の例（全13件）

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Horiba Ltd.
  • Merck & Co., Inc.
  • PerkinElmer, Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10938

Global Cell Counting Market to Reach US$22.0 Billion by 2030

The global market for Cell Counting estimated at US$15.3 Billion in the year 2023, is expected to reach US$22.0 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Cell Counting Consumables, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$12.9 Billion by the end of the analysis period. Growth in the Cell Counting Instruments segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.2 Billion While China is Forecast to Grow at 5.0% CAGR

The Cell Counting market in the U.S. is estimated at US$4.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 5.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Cell Counting Market - Key Trends and Drivers Summarized

How Is Cell Counting Advancing Research in Biotechnology and Medicine?

Cell counting has become a fundamental technique in biotechnology, life sciences, and medical research, providing critical insights into cellular behavior, growth, and response to treatments. This process involves quantifying cells in a given sample, which is essential for a wide range of applications, from assessing cell viability in drug screening to determining concentrations in cell culture. Cell counting is indispensable in fields such as cancer research, where understanding cell proliferation rates can directly influence the development of new therapies. It is also crucial in biopharmaceutical production, where accurate cell counts are necessary for consistent product yields and quality control. Moreover, cell counting is extensively used in immunology, microbiology, and hematology to monitor disease progression and the effectiveness of therapeutic interventions. Whether for research, diagnostics, or therapeutic development, the precision and efficiency of modern cell counting methods are playing a pivotal role in advancing scientific knowledge and medical innovation.

Why Is There a Growing Demand for Automated Cell Counting Technologies?

The growing demand for automated cell counting technologies stems from the need for accuracy, efficiency, and scalability in both research and clinical settings. Manual cell counting, often performed using a hemocytometer under a microscope, is labor-intensive, prone to human error, and unsuitable for high-throughput applications. In contrast, automated cell counting systems offer rapid, precise, and reproducible results, enabling researchers and clinicians to process large sample volumes in significantly less time. These systems are particularly valuable in pharmaceutical research, where the ability to rapidly analyze cell viability and proliferation across hundreds or thousands of samples is critical for drug discovery and development. Additionally, the rising complexity of biological research, especially in fields like oncology, stem cell research, and regenerative medicine, requires more sophisticated tools to handle the increasing volume of cell-based experiments. Automated cell counters equipped with advanced imaging and flow cytometry capabilities are meeting these needs by delivering high-resolution data and supporting complex assays, such as those involving heterogeneous cell populations. The integration of user-friendly software interfaces and data analysis tools further enhances the appeal of these systems, driving their adoption across laboratories and hospitals worldwide.

How Are Technological Advancements Transforming Cell Counting Techniques?

Technological advancements are transforming cell counting, improving both the accuracy and functionality of the tools available to researchers and clinicians. Innovations such as flow cytometry, image-based cell counting, and microfluidic devices are enabling more precise and high-throughput cell analysis. Flow cytometry, in particular, allows for the simultaneous counting and characterization of thousands of cells based on their physical and chemical properties, making it ideal for applications such as immunophenotyping and cancer research. Image-based cell counting, which uses advanced microscopy and software algorithms to analyze cell images, has become increasingly popular for its ability to provide detailed data on cell morphology and viability. Additionally, the emergence of label-free technologies, which allow for real-time monitoring of cell growth without the need for dyes or stains, is reducing the impact of external agents on the cells being studied, thus preserving their natural behavior. Automated systems that incorporate artificial intelligence (AI) and machine learning are further enhancing the capabilities of cell counting technologies, providing more accurate predictions and analysis of cellular behavior based on large datasets. These innovations are making cell counting faster, more reliable, and more versatile, expanding its applications in research and clinical diagnostics.

What Are the Key Growth Drivers in the Cell Counting Market?

The growth in the cell counting market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in biotechnology, and the growing demand for personalized medicine. One of the primary drivers is the rising need for accurate cell analysis in disease research and diagnostics. As the global incidence of cancer, diabetes, and infectious diseases continues to increase, cell counting technologies are essential for monitoring disease progression and evaluating the effectiveness of therapies. Additionally, the expansion of the biopharmaceutical industry, particularly in the production of biologics and vaccines, has intensified the demand for precise cell counting to ensure consistent product quality. Technological advancements, such as the development of automated, high-throughput cell counting systems, are further fueling market growth by improving the speed and accuracy of research workflows. The growing trend toward personalized medicine, which requires precise cell analysis to tailor treatments to individual patients, is also boosting demand for advanced cell counting technologies. Moreover, the increasing use of stem cells in regenerative medicine and the expansion of cell-based assays in drug development are creating new opportunities for cell counting solutions. Lastly, the adoption of cell counting technologies in clinical diagnostics, particularly in hematology and immunology, continues to drive market expansion as healthcare providers seek more accurate tools for patient care. These factors, combined with the growing investment in life sciences research, are expected to sustain the robust growth of the cell counting market in the coming years.

Select Competitors (Total 13 Featured) -

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Horiba Ltd.
  • Merck & Co., Inc.
  • PerkinElmer, Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cell Counting - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Adoption of Automated Cell Counters Expands the Addressable Market for Cell Counting Solutions
    • Here's How Advancements in Flow Cytometry Propel Innovation in Cell Counting Methods
    • Growing Use of Cell Counting in Cancer Research Strengthens Market Demand
    • Rising Focus on Stem Cell Research and Therapy Spurs Adoption of Advanced Cell Counting Techniques
    • Here's How High-Throughput Screening in Drug Discovery Generates Demand for Automated Cell Counting
    • Technological Advancements in Image-Based Cell Counting Accelerate Market Growth
    • Growing Application of Cell Counting in Biologics and Vaccine Production Drives Demand
    • Rising Investments in Biotechnology and Life Sciences Propel Growth in Cell Counting Markets
    • Expanding Use of Cell Counting in Immunology and Infectious Disease Research Creates New Opportunities
    • Rising Incidence of Chronic Diseases Drives the Need for Accurate Cell Quantification in Clinical Diagnostics
    • Growing Adoption of Microfluidic Technologies Enhances Accuracy and Efficiency in Cell Counting
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Counting Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Counting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cell Counting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cell Counting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cell Counting by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cell Counting by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Cell Counting by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION